Goldman Sachs’s Fennec Pharmaceuticals FENC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$132K Sell
15,938
-27,282
-63% -$226K ﹤0.01% 4826
2025
Q1
$263K Sell
43,220
-27,977
-39% -$170K ﹤0.01% 4567
2024
Q4
$450K Buy
71,197
+17,444
+32% +$110K ﹤0.01% 4344
2024
Q3
$269K Buy
53,753
+33,619
+167% +$168K ﹤0.01% 4391
2024
Q2
$123K Sell
20,134
-22,957
-53% -$140K ﹤0.01% 4475
2024
Q1
$479K Buy
43,091
+12,091
+39% +$134K ﹤0.01% 4008
2023
Q4
$348K Buy
31,000
+13,664
+79% +$153K ﹤0.01% 4107
2023
Q3
$130K Sell
17,336
-13,496
-44% -$101K ﹤0.01% 4345
2023
Q2
$272K Buy
30,832
+10,081
+49% +$89K ﹤0.01% 4274
2023
Q1
$173K Sell
20,751
-234
-1% -$1.95K ﹤0.01% 4563
2022
Q4
$201K Buy
+20,985
New +$201K ﹤0.01% 4501
2022
Q3
Sell
-10,029
Closed -$56K 5531
2022
Q2
$56K Sell
10,029
-3,051
-23% -$17K ﹤0.01% 5260
2022
Q1
$73K Sell
13,080
-368
-3% -$2.05K ﹤0.01% 5389
2021
Q4
$59K Buy
13,448
+16
+0.1% +$70 ﹤0.01% 5321
2021
Q3
$127K Buy
13,432
+34
+0.3% +$321 ﹤0.01% 5009
2021
Q2
$98K Sell
13,398
-7,659
-36% -$56K ﹤0.01% 5127
2021
Q1
$131K Sell
21,057
-3,614
-15% -$22.5K ﹤0.01% 4963
2020
Q4
$184K Sell
24,671
-129
-0.5% -$962 ﹤0.01% 4302
2020
Q3
$150K Sell
24,800
-5,761
-19% -$34.8K ﹤0.01% 4146
2020
Q2
$255K Buy
30,561
+16,337
+115% +$136K ﹤0.01% 3894
2020
Q1
$84K Hold
14,224
﹤0.01% 4196
2019
Q4
$92K Buy
+14,224
New +$92K ﹤0.01% 4136
2018
Q4
Sell
-10,438
Closed -$86K 4134
2018
Q3
$86K Sell
10,438
-6,552
-39% -$54K ﹤0.01% 3977
2018
Q2
$177K Sell
16,990
-1,008
-6% -$10.5K ﹤0.01% 3904
2018
Q1
$218K Buy
+17,998
New +$218K ﹤0.01% 3820